Supriya Lifescience Limited
NSE:SUPRIYA.NS
648.3 (INR) • At close November 8, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Omzet
| 5,703.7 | 4,609.38 | 5,193.74 | 3,853.65 | 3,116.45 | 2,778.4 | 2,129.14 |
| Kosten van de omzet
| 3,051.9 | 1,808.12 | 2,298.864 | 1,511.67 | 1,627.47 | 1,735.2 | 1,778.17 |
| Brutowinst
| 2,651.8 | 2,801.26 | 2,894.876 | 2,341.98 | 1,488.98 | 1,043.2 | 350.97 |
| Brutowinstmarge
| 0.465 | 0.608 | 0.557 | 0.608 | 0.478 | 0.375 | 0.165 |
| Onderzoek- en ontwikkelingskosten
| 10.85 | 12.37 | 16.62 | 6.61 | 10.57 | 7.78 | 7.06 |
| Algemene en administratieve kosten
| 676.38 | 192.26 | 137.32 | 105.17 | 104.8 | 69.5 | 162.96 |
| Verkoop- en marketingkosten
| 185.88 | 238.67 | 223.75 | 231.2 | 135.38 | 113.72 | 67.27 |
| Verkoop-, algemene en administratieve kosten
| 1,080.15 | 430.93 | 361.07 | 336.37 | 240.18 | 183.22 | 166.47 |
| Overige kosten
| 106.35 | 94.89 | 0.11 | 39.69 | 83.55 | 48.14 | -10.53 |
| Bedrijfskosten
| 1,080.15 | 1,630.42 | 873.31 | 735.79 | 564.45 | 432.22 | 184.06 |
| Bedrijfsresultaat
| 1,571.65 | 1,171.68 | 2,043.39 | 1,663.85 | 1,008.07 | 610.98 | 166.91 |
| Bedrijfsresultaat ratio
| 0.276 | 0.254 | 0.393 | 0.432 | 0.323 | 0.22 | 0.078 |
| Totaal overige inkomsten en kosten netto
| 85.25 | 63.19 | 29.06 | 9.24 | -45.8 | -39.94 | -22.27 |
| Inkomen voor belasting
| 1,656.9 | 1,234.87 | 2,072.45 | 1,673.93 | 962.27 | 571.04 | 144.64 |
| Inkomen voor belasting ratio
| 0.29 | 0.268 | 0.399 | 0.434 | 0.309 | 0.206 | 0.068 |
| Belastingkosten
| 465.76 | 336.3 | 554.35 | 435.65 | 228.24 | 176.79 | 57.36 |
| Nettowinst
| 1,191.14 | 898.57 | 1,518.1 | 1,235.93 | 734.03 | 394.24 | 87.28 |
| Nettowinstmarge
| 0.209 | 0.195 | 0.292 | 0.321 | 0.236 | 0.142 | 0.041 |
| WPA (Winst Per Aandeel)
| 14.8 | 11.16 | 18.86 | 16.89 | 10.03 | 15.43 | 1.19 |
| Verwaterde WPA
| 14.8 | 11.16 | 18.86 | 16.89 | 10.03 | 15.43 | 1.19 |
| EBITDA
| 1,729.76 | 1,383.86 | 2,205.43 | 1,781.26 | 1,089.12 | 702.54 | 220.23 |
| EBITDA ratio
| 0.303 | 0.3 | 0.425 | 0.462 | 0.349 | 0.253 | 0.103 |